Baidu
map

儿科指南

订阅

MedSci主页 / 所有栏目 / 儿科指南

澳大利亚和新西兰轻中度儿童颅脑损伤指南 2021

2021-02-10 Emerg Med Australas . 2021 Feb 2. doi: 10.1111/1742-6723.13722

癌症

目的：儿童经常因急性护理而头部受伤。尽管存在国际颅脑损伤的儿科临床实践指南，但它们并未解决与澳大利亚和新西兰相关的轻度至中度颅脑损伤的分类，影像学，观察与入院，转移，出院和随访有关的所有考虑。急诊科国

中文标题：

澳大利亚和新西兰轻中度儿童颅脑损伤指南 2021

英文标题：

Australian and New Zealand Guideline for Mild to Moderate Head Injuries in Children

发布机构：

发布日期：

2021-02-10

简要介绍：

目的：儿童经常因急性护理而头部受伤。尽管存在国际颅脑损伤的儿科临床实践指南，但它们并未解决与澳大利亚和新西兰相关的轻度至中度颅脑损伤的分类，影像学，观察与入院，转移，出院和随访有关的所有考虑。急诊科国际合作儿科研究（PREDICT）着手制定基于证据的，适用于当地的实用临床指南，以照顾出现在急性护理环境中的轻度至中度颅脑损伤的儿童。

方法：一个多学科指南工作组（GWG）在三个关键领域提出了33个问题-分流，影像学检查以及出院至急诊就诊的轻度至中度颅脑损伤儿童的出院情况。我们确定了现有的高质量指南，并从这些指南中将建议映射到临床问题。进行了更新的文献检索，并确定了关键的新证据。通过采用，改编或制定新的建议来创建建议。经过一段时间的公众咨询后，对指南进行了修订。

结果：GWG提出了与澳大利亚和新西兰背景相关的71项建议（依据证据的建议= 35，基于共识的建议= 17，实践要点= 19）。该指南以三份文件的形式呈现：（i）详细的完整指南，总结了每个建议的依据； （ii）指南摘要； （iii）临床算法：患有颅脑损伤的儿童的成像和观察决策。

结论：PREDICT澳大利亚和新西兰儿童轻度至中度颅脑损伤指南为一线临床医生提供了高水平的证据和实用指南。

相关资料下载：
[AttachmentFileName(sort=1, fileName=66.pdf)] GetToolGuiderByIdResponse(projectId=1, id=20c191c00205a2d0, title=澳大利亚和新西兰轻中度儿童颅脑损伤指南 2021, enTitle=Australian and New Zealand Guideline for Mild to Moderate Head Injuries in Children, guiderFrom=Emerg Med Australas . 2021 Feb 2. doi: 10.1111/1742-6723.13722, authorId=0, author=, summary=目的：儿童经常因急性护理而头部受伤。尽管存在国际颅脑损伤的儿科临床实践指南，但它们并未解决与澳大利亚和新西兰相关的轻度至中度颅脑损伤的分类，影像学，观察与入院，转移，出院和随访有关的所有考虑。急诊科国, cover=, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Wed Feb 10 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span class="VIiyi" lang="zh-CN"><span class="JLqJ4b" data-language-for-alternatives="zh-CN" data-language-to-translate-into="en" data-phrase-index="0">目的：儿童经常因急性护理而头部受伤。尽管存在国际颅脑损伤的儿科临床实践指南，但它们并未解决与澳大利亚和新西兰相关的轻度至中度颅脑损伤的分类，影像学，观察与入院，转移，出院和随访有关的所有考虑。急诊科国际合作儿科研究（PREDICT）着手制定基于证据的，适用于当地的实用临床指南，以照顾出现在急性护理环境中的轻度至中度颅脑损伤的儿童。 </span></span></p> <p><span class="VIiyi" lang="zh-CN"><span class="JLqJ4b" data-language-for-alternatives="zh-CN" data-language-to-translate-into="en" data-phrase-index="0">方法：一个多学科指南工作组（GWG）在三个关键领域提出了33个问题-分流，影像学检查以及出院至急诊就诊的轻度至中度颅脑损伤儿童的出院情况。我们确定了现有的高质量指南，并从这些指南中将建议映射到临床问题。进行了更新的文献检索，并确定了关键的新证据。通过采用，改编或制定新的建议来创建建议。经过一段时间的公众咨询后，对指南进行了修订。 </span></span></p> <p><span class="VIiyi" lang="zh-CN"><span class="JLqJ4b" data-language-for-alternatives="zh-CN" data-language-to-translate-into="en" data-phrase-index="0">结果：GWG提出了与澳大利亚和新西兰背景相关的71项建议（依据证据的建议= 35，基于共识的建议= 17，实践要点= 19）。该指南以三份文件的形式呈现：（i）详细的完整指南，总结了每个建议的依据； （ii）指南摘要； （iii）临床算法：患有颅脑损伤的儿童的成像和观察决策。 </span></span></p> <p><span class="VIiyi" lang="zh-CN"><span class="JLqJ4b" data-language-for-alternatives="zh-CN" data-language-to-translate-into="en" data-phrase-index="0">结论：PREDICT澳大利亚和新西兰儿童轻度至中度颅脑损伤指南为一线临床医生提供了高水平的证据和实用指南。</span></span></p>, tagList=[TagDto(tagId=516, tagName=癌症)], categoryList=[CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=25, categoryName=神经外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=9, opened=0, paymentType=, paymentAmount=20, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=12318, appHits=113, showAppHits=0, pcHits=463, showPcHits=12202, likes=0, shares=25, comments=22, approvalStatus=1, publishedTime=Wed Feb 10 21:26:57 CST 2021, publishedTimeString=2021-02-10, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=fbzhang, createdTime=Wed Feb 10 21:26:51 CST 2021, updatedBy=4754896, updatedName=fbzhang, updatedTime=Mon Jan 01 20:52:31 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=66.pdf)])
66.pdf
下载请点击：
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1217740, encodeId=450a121e740f1, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200727/736ba40afe5c4233a93f98f570087092/e84b9f4f3a0a439199188c18614e89d3.jpg, createdBy=641c2797366, createdName=jwbchn, createdTime=Sat May 07 23:57:42 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978760, encodeId=bd259e876032, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4515212333, createdName=14761874m39暂无昵称, createdTime=Thu Jul 01 20:50:27 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978538, encodeId=ad559e853853, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca05515966, createdName=神经小医生, createdTime=Thu Jul 01 10:11:10 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924243, encodeId=b5289242433a, content=谢谢分享了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210220/0e150cf15def40f5aad1e87852fea438/9ce298d8c77b4ed5848862be14da3b50.jpg, createdBy=b1425447761, createdName=ms7000001623538615, createdTime=Fri Feb 12 07:59:16 CST 2021, time=2021-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924227, encodeId=f4eb92422e9c, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/50a003c4097845e182c08afd64d8a509/bd766dfebe9c40e0bca2dae964601bdc.jpg, createdBy=22de5454917, createdName=carrotlyl, createdTime=Fri Feb 12 07:45:22 CST 2021, time=2021-02-12, status=1, ipAttribution=)]
    2022-05-07 jwbchn

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1217740, encodeId=450a121e740f1, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200727/736ba40afe5c4233a93f98f570087092/e84b9f4f3a0a439199188c18614e89d3.jpg, createdBy=641c2797366, createdName=jwbchn, createdTime=Sat May 07 23:57:42 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978760, encodeId=bd259e876032, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4515212333, createdName=14761874m39暂无昵称, createdTime=Thu Jul 01 20:50:27 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978538, encodeId=ad559e853853, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca05515966, createdName=神经小医生, createdTime=Thu Jul 01 10:11:10 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924243, encodeId=b5289242433a, content=谢谢分享了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210220/0e150cf15def40f5aad1e87852fea438/9ce298d8c77b4ed5848862be14da3b50.jpg, createdBy=b1425447761, createdName=ms7000001623538615, createdTime=Fri Feb 12 07:59:16 CST 2021, time=2021-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924227, encodeId=f4eb92422e9c, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/50a003c4097845e182c08afd64d8a509/bd766dfebe9c40e0bca2dae964601bdc.jpg, createdBy=22de5454917, createdName=carrotlyl, createdTime=Fri Feb 12 07:45:22 CST 2021, time=2021-02-12, status=1, ipAttribution=)]
    2021-07-01 14761874m39暂无昵称

    学习中

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1217740, encodeId=450a121e740f1, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200727/736ba40afe5c4233a93f98f570087092/e84b9f4f3a0a439199188c18614e89d3.jpg, createdBy=641c2797366, createdName=jwbchn, createdTime=Sat May 07 23:57:42 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978760, encodeId=bd259e876032, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4515212333, createdName=14761874m39暂无昵称, createdTime=Thu Jul 01 20:50:27 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978538, encodeId=ad559e853853, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca05515966, createdName=神经小医生, createdTime=Thu Jul 01 10:11:10 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924243, encodeId=b5289242433a, content=谢谢分享了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210220/0e150cf15def40f5aad1e87852fea438/9ce298d8c77b4ed5848862be14da3b50.jpg, createdBy=b1425447761, createdName=ms7000001623538615, createdTime=Fri Feb 12 07:59:16 CST 2021, time=2021-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924227, encodeId=f4eb92422e9c, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/50a003c4097845e182c08afd64d8a509/bd766dfebe9c40e0bca2dae964601bdc.jpg, createdBy=22de5454917, createdName=carrotlyl, createdTime=Fri Feb 12 07:45:22 CST 2021, time=2021-02-12, status=1, ipAttribution=)]
    2021-07-01 神经小医生

    学习中

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1217740, encodeId=450a121e740f1, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200727/736ba40afe5c4233a93f98f570087092/e84b9f4f3a0a439199188c18614e89d3.jpg, createdBy=641c2797366, createdName=jwbchn, createdTime=Sat May 07 23:57:42 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978760, encodeId=bd259e876032, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4515212333, createdName=14761874m39暂无昵称, createdTime=Thu Jul 01 20:50:27 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978538, encodeId=ad559e853853, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca05515966, createdName=神经小医生, createdTime=Thu Jul 01 10:11:10 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924243, encodeId=b5289242433a, content=谢谢分享了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210220/0e150cf15def40f5aad1e87852fea438/9ce298d8c77b4ed5848862be14da3b50.jpg, createdBy=b1425447761, createdName=ms7000001623538615, createdTime=Fri Feb 12 07:59:16 CST 2021, time=2021-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924227, encodeId=f4eb92422e9c, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/50a003c4097845e182c08afd64d8a509/bd766dfebe9c40e0bca2dae964601bdc.jpg, createdBy=22de5454917, createdName=carrotlyl, createdTime=Fri Feb 12 07:45:22 CST 2021, time=2021-02-12, status=1, ipAttribution=)]
    2021-02-12 ms7000001623538615

    谢谢分享了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1217740, encodeId=450a121e740f1, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200727/736ba40afe5c4233a93f98f570087092/e84b9f4f3a0a439199188c18614e89d3.jpg, createdBy=641c2797366, createdName=jwbchn, createdTime=Sat May 07 23:57:42 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978760, encodeId=bd259e876032, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4515212333, createdName=14761874m39暂无昵称, createdTime=Thu Jul 01 20:50:27 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978538, encodeId=ad559e853853, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fca05515966, createdName=神经小医生, createdTime=Thu Jul 01 10:11:10 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924243, encodeId=b5289242433a, content=谢谢分享了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210220/0e150cf15def40f5aad1e87852fea438/9ce298d8c77b4ed5848862be14da3b50.jpg, createdBy=b1425447761, createdName=ms7000001623538615, createdTime=Fri Feb 12 07:59:16 CST 2021, time=2021-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924227, encodeId=f4eb92422e9c, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/50a003c4097845e182c08afd64d8a509/bd766dfebe9c40e0bca2dae964601bdc.jpg, createdBy=22de5454917, createdName=carrotlyl, createdTime=Fri Feb 12 07:45:22 CST 2021, time=2021-02-12, status=1, ipAttribution=)]
    2021-02-12 carrotlyl

    感谢

    0

相关指南

西班牙内科医学会和西班牙医学肿瘤学会就癌症患者继发血栓预防的共识声明

西班牙内科协会（Spanish Society of Internal Medicine） · 2020-09-08

2020 欧洲指南：Li-Fraumeni和遗传性TP53相关癌症综合征

国外肿瘤科相关专家小组（统称） · 2020-05-26

2020 ESMO共识建议：癌症患者在肿瘤治疗过程中心脏病的管理

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2020-02-01

2020 SGO临床实践声明：大麻素类药物在癌症患者中的应用

美国妇科肿瘤学会(SGO,Society of Gynecologic Oncology) · 2020-01-10

2018 ESMO临床实践指南：癌症患者腹泻

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2018-06-21

Baidu
map
Baidu
map
Baidu
map